CapitolMarkets
Julia Letlow
Julia Letlow
RHouseRepresentative · Louisiana

Sold up to $15,000 of Bristol-Myers Squibb (BMY)

Trade dated Apr 28, 2025260 days to disclose · 215 past 45-day window
BMY since the sale
+16.8%
S&P 500, same window
+37.4%
▼ BMY trailed the S&P 500 by 20.6 points since the sale

Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

  1. Mar 10, 2025Legislation
    Cosponsored HR 1262
    Pharmaceutical sector
  2. Mar 11, 2025Floor vote
    Voted Yea on Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Internal Revenue Service relating to "Gross Proceeds Reporting by Brokers That Regularly Provide Services Effectuating Digital Asset Sales".
    Result: Passed
  3. Mar 14, 2025Legislation
    Cosponsored HR 842
    Pharmaceutical sector
  4. Mar 31, 2025Floor vote
    Voted Yea on National Taxpayer Advocate Enhancement Act of 2025
    Result: Passed
  5. Apr 1, 2025Legislation
    Cosponsored HR 943
    Pharmaceutical sector
  6. Apr 1, 2025Legislation
    Cosponsored HR 2552
    Pharmaceutical sector
  7. Apr 28, 2025Trade
    Sold up to $15,000 of BMY
  8. Jun 25, 2025Legislation
    Cosponsored HR 4132
    Pharmaceutical sector
  9. Jan 13, 2026Disclosure
    Disclosed the trade
    Public filing
Source: U.S. House Clerk (disclosures-clerk.house.gov)
Get an alert the moment Julia Letlow files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.

Get filing alertsSee all of Letlow's trades